Intrexon Energy Partners II

Intrexon Energy Partners II was a joint venture formed to commercialize Intrexon Corporation's proprietary methanotroph bioconversion platform for the energy and chemical sectors. The company focused on engineering methanotrophic bacteria to convert natural gas into high-value industrial chemicals and fuels, specifically targeting the production of isobutanol. This initiative was part of a broader strategy to apply synthetic biology to industrial markets by utilizing methane as a low-cost feedstock. Following Intrexon's rebranding to Precigen in 2020 and its subsequent strategic pivot toward healthcare and gene therapy, the energy-focused assets and partnerships were largely discontinued or divested.